WallStreetZenWallStreetZen

NASDAQ: CYTK
Cytokinetics Inc Stock Ownership - Who owns Cytokinetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cytokinetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert I. BlumCEO;Pres2026-08-107,500$10.60
$79.50kBuy
Robert I. BlumCEO;Pres2026-08-107,500$76.76
$575.70kSell
Andrew CallosCCO;EVP2026-07-3014,000$23.26
$325.64kBuy
Andrew CallosCCO;EVP2026-07-3014,000$79.88
$1.12MSell
Robert I. BlumCEO;Pres2026-07-277,500$10.60
$79.50kBuy
Robert I. BlumCEO;Pres2026-07-277,500$80.87
$606.53kSell
Fady Ibraham MalikEVP2026-07-213,500$7.80
$27.30kBuy
Fady Ibraham MalikEVP2026-07-213,500$80.59
$282.07kSell
Wendell WierengaDirector2026-07-1575$82.62
$6.20kBuy
James M. DalyDirector2026-07-15151$82.62
$12.48kBuy

1 of 18

CYTK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYTK insiders and whales buy or sell their stock.

CYTK Shareholders

What type of owners hold Cytokinetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc12.60%17,523,840$1.34BInstitution
Blackrock Inc11.90%16,548,011$1.27BInstitution
Fmr LLC7.71%10,723,140$819.78MInstitution
Michael Schmertzler7.00%9,730,131$743.87MInsider
Wellington Management Group LLP5.76%8,009,489$612.33MInstitution
Vanguard Portfolio Management LLC4.20%5,843,782$446.76MInstitution
State Street Corp4.13%5,745,193$439.22MInstitution
Vanguard Capital Management LLC3.95%5,488,634$419.61MInstitution
Avoro Capital Advisors LLC2.40%3,333,333$254.83MInstitution
Geode Capital Management LLC2.31%3,215,415$245.82MInstitution

1 of 3

CYTK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYTK90.50%9.50%Net SellingNet Selling
PRAX69.37%30.63%Net SellingNet Buying
APGE95.26%4.74%Net SellingNet Selling
ABVX63.37%0.00%
KRYS79.66%20.34%Net SellingNet Selling
View Top Biotech Stocks

Cytokinetics Stock Ownership FAQ

Who owns Cytokinetics?

Cytokinetics (NASDAQ: CYTK) is owned by 105.08% institutional shareholders, 11.03% Cytokinetics insiders, and 0.00% retail investors. Michael Schmertzler is the largest individual Cytokinetics shareholder, owning 9.73M shares representing 7.00% of the company. Michael Schmertzler's Cytokinetics shares are currently valued at $735.99M.

If you're new to stock investing, here's how to buy Cytokinetics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.